Beta Bionics, Inc. Common Stock BBNX Ratios & Valuation
| FY'25 | FY'24 | ||
|---|---|---|---|
| Profitability | |||
| Gross margin | 55.4%+0.3pp | 55.1%+2.5pp | |
| Operating margin | -71.5%-2.0pp | -69.5%+229pp | |
| Net margin | -73%+11.1pp | -84.1%+284pp | |
| Efficiency | |||
| Asset turnover | 0.4×-0.1× | 0.5×— | |
| Liquidity | |||
| Current ratio | 8.7×+2.4× | 6.3×-3.5× | |
| Leverage | |||
| Debt-to-equity | 0×— | —— | |
| Per Share | |||
| Book value per share | $7.10+118% | -$38.55-0.7% | |
| Valuation | |||
| Market capitalization | $708.98M-8.6% | —— | |
| Price / sales | 6.4×— | —— | |
| Price / book | 2.6×— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Beta Bionics, Inc. Common Stock's profit margins?
- Beta Bionics, Inc. Common Stock (BBNX) runs a 57.2% gross margin and a -70.1% operating margin, with a -60.3% net margin.
- Where do Beta Bionics, Inc. Common Stock's ratios come from?
- Every ratio is computed from Beta Bionics, Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
